C Mitsiades
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 3
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Nicholas MitsiadesV. PoulakiMaria TsokosVassiliki PoulakiJ D GriffinEllen WeisbergAmanda L. ChristieMartin Sattler
- Journals
- Blood (3 papers)Leukemia (2 papers)Journal of Clinical Oncology (1 paper)APOPTOSIS (1 paper)Drug Resistance Updates (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
C Mitsiades
12 papers receiving 337 citations
Peers
Comparison fields: 5 of 50
- Hematology 97
- Cancer Research 61
- Oncology 106
- Molecular Biology 236
- Genetics 32
Countries citing papers authored by C Mitsiades
This map shows the geographic impact of C Mitsiades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Mitsiades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Mitsiades more than expected).
Fields of papers citing papers by C Mitsiades
This network shows the impact of papers produced by C Mitsiades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Mitsiades. The network helps show where C Mitsiades may publish in the future.
Co-authors
The 25 scholars most cited alongside C Mitsiades, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 49 | |
| 2 | 2012 | 61 | |
| 3 | 2009 | 2 | |
| 4 | 2009 | 4 | |
| 5 | 2006 | 8 | |
| 6 | 2005 | 7 | |
| 7 | 2004 | 25 | |
| 8 | Gene expression analysis of tumor cells sensitive and resistant to PS-341 (Bortezomib) treatment: Clinical implications. | 2003 | 1 |
| 9 | LAQ824 is a novel histone deacetylase inhibitor with significant activity against multiple myeloma: Results of a pre-clinical evaluation in vitro and in vivo. | 2002 | 5 |
| 10 | Heat shock protein-27 confers drug-resistance in multiple myeloma cells. | 2002 | 2 |
| 11 | 2001 | 71 | |
| 12 | Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. | 2001 | 109 |
About C Mitsiades
C Mitsiades is a scholar working on Hematology, Genetics, Oncology, Cancer Research and Molecular Biology, having authored 12 papers that have together received 344 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers), Cell death mechanisms and regulation (2 papers), Peptidase Inhibition and Analysis (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Heat shock proteins research (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Hematology (97 citations), Cancer Research (61 citations), Oncology (106 citations), Molecular Biology (236 citations) and Genetics (32 citations). C Mitsiades has collaborated with scholars based in United States and China. Frequent co-authors include Nicholas Mitsiades, V. Poulaki, Maria Tsokos, Vassiliki Poulaki, J D Griffin, Ellen Weisberg, Amanda L. Christie, Martin Sattler, Erik A. Nelson and Nathanael S. Gray. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, APOPTOSIS and Drug Resistance Updates.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.